Curaleaf opened their second cannabis dispensary location in Sarasota, Florida. This marked the opening of their 61st store.
In a recent press release (1), Curaleaf Holdings, Inc. (Curaleaf), unveiled that they had opened their second cannabis dispensary in Sarasota, Florida. It was also marked as the 61st location for the company. The new dispensary can be found at 3704 84th Avenue Circle E, Sarasota, Florida.
In the state of Florida, only medical cannabis is legalized and recreational use is still considered illegal. The new Sarasota location will be open Monday to Saturday from 9am to 8:30pm EST and on Sundays will be accessible from 10am to 7pm EST (1). This business will offer to medical cannabis patients a variety of products. In the press release (1), they mentioned, “an extensive selection of flower and pre-rolls, JAMS and Blue Kudu edibles, as well as the top-selling Select line, including Select Briq, Select Live Rosin, Select Live Rosin X Bites and the innovative vape hardware, Cliq by Select.” Staff members will be able to assist customers with their purchases and will also have the option to purchase items online to be picked up inside the store or via curbside pickup.
"Florida is an important market for us, and Sarasota is a vibrant, populous community that has welcomed Curaleaf with open arms since we launched our first medical dispensary in the area in 2019," Matt Darin, CEO of Curaleaf, commented (1). "We are thrilled to open a second location in this beautiful city to further expand access to the highest quality cannabis on the market, grow our business and build a deeper connection with the people of Sarasota."
At the new dispensary, medical cannabis patients will be able to utilize the company’s rewards program where they will be able to obtain loyalty points from every dollar spent on their order. Those points can then be used on future purchases at any of their 61 cannabis dispensary locations (1).
Reference
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.